Correlation of degree of tumor immune infiltration and insertion-and-deletion (indel) burden with outcome on programmed death 1 (PD1) therapy in advanced renal cell cancer (RCC).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Martin Henner Voss, Jacqueline Buros Novik, Matthew David Hellmann, Mark Ball, A. Ari Hakimi, Diana Miao, Claire Margolis, Christine Horak, Megan Wind-Rotolo, Guillermo De Velasco, Nizar M. Tannir, Pheroze Tamboli, Leonard Joseph Appleman, Kimryn Rathmell, James J Hsieh, Mohamad Allaf, Toni K. Choueiri, Eliezer VanAllen, Alexandra Snyder, Robert J. Motzer
Institutions: Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, National Cancer Institute, Dana-Farber Cancer Institute, Bristol-Myers Squibb (United States), Hospital Universitario 12 De Octubre, The University of Texas MD Anderson Cancer Center, University of Pittsburgh Medical Center, Vanderbilt University Medical Center, Washington University in St. Louis, Johns Hopkins University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890629916